Prevention of early pregnancy loss in autoantibody seropositive women [3]

Lancet

Volumn 351, Issue 9095, 1998, Pages 34-35

  Geva, Eli ^b   Amit, Ami ^b   Lerner Geva, Liat ^b   Lessing, Joseph B ^a  

^a LIS MATERNITY HOSPITAL   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; PREDNISONE;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MAJOR CLINICAL STUDY; NIDATION; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION;

EID: 0032477582     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78093-4     Document Type: Article

References (4)

1. 1 Geva E, Amit A, Lerner-Geva L, Lessing JB. Autoimmunity and reproduction. Fertil Steril 1997; 67: 599-61.
2. 2 Geva E, Yaron Y, Lessing JB, et al. Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil Steril 1994; 62: 802-06.
3. 3 Rote NS, Walter A, Lyden TW. Antiphospholipid antibodies - lobsters or red herrings? Am J Reprod Immunol 1992; 28: 31-37.
4. 4 Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337: 148-53.